A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Recent Filings
- SC 13G/A11.7 KBANADYS PHARMACEUTICALS INCFeb 14, 3:34 PM ET·0001172661-12-000251
- 8-K20.1 KBANADYS PHARMACEUTICALS INCNov 30, 3:03 PM ET·0001193125-11-325909
- SC 13G/A136.0 KBANADYS PHARMACEUTICALS INCNov 14, 4:54 PM ET·0001318148-11-002058
- 10-Q1.7 MBANADYS PHARMACEUTICALS INCNov 7, 5:01 PM ET·0001193125-11-299984
- 8-K54.8 KBANADYS PHARMACEUTICALS INCNov 7, 4:08 PM ET·0001299933-11-003253
- SC 13D/A102.0 KBANADYS PHARMACEUTICALS INCNov 4, 4:34 PM ET·0001193125-11-297502
- SC 13D/A102.0 KBANADYS PHARMACEUTICALS INCOct 31, 9:29 AM ET·0001193125-11-287409
- SC 13D133.1 KBANADYS PHARMACEUTICALS INCOct 25, 9:33 PM ET·0001193125-11-280767
- SC 13D/A89.6 KBANADYS PHARMACEUTICALS INCOct 25, 9:34 AM ET·0000950123-11-091663
- 48.5 KBANADYS PHARMACEUTICALS INCOct 24, 4:54 PM ET·0001209191-11-052489
Insiders
10- Appleman James R.SVP, Research & CSO
- AVERETT DEVRON RChief Scientific Officer
- Eastwood Kevin L.SVP, Corporate Development
- FISHERMAN JASON SDirector
- FOLETTA MARK GDirector
- FOTIADIS MARIOSDirector
- Freddo James LSVP, Drug Development and CMO
- Gallagher Carol GiltnerVP, Corp. Dev. & Comm. Affairs
- GLOVER JAMES TSVP, Operations and CFO
- HBM BIOVENTURES AG10% Owner
Tickers
No tickers on record
Addresses
business
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO, CA, 92121
mailing
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO, CA, 92121